The IPO consists of a fresh issue of 33.1 lakh shares worth Rs 44.75 crore and an offer for sale of 3.34 lakh shares worth Rs 4.51 crore. Of the total 36.49 lakh shares on offer, 47.47% have been reserved for retail investors and an equal portion for high-net-worth individuals (HNIs).
Retail investors must apply for a minimum of 2,000 shares, amounting to Rs 2.7 lakh, while HNIs need to bid for at least 3,000 shares or Rs 4.05 lakh.
Earkart is a HealthTech platform specialising in hearing aids and related accessories. The company also distributes foldable walkers and specialised educational material for the physically challenged.
The company operates through multiple channels—online, offline, and government supply. It is a registered supplier on the Government e-Marketplace (GeM) and supplies hearing aids to Alimco under the government.
To expand its reach, Earkart launched a Shop-in-Shop (SIS) model in 2024, offering franchises to opticians and ENT/optical clinics. It currently runs 49 SIS clinics across 22 cities in six states and two Union Territories.Financially, the company has shown strong growth. Revenue rose 35% year-on-year to Rs 43.19 crore in FY25 from Rs 31.97 crore in FY24. Profit after tax more than doubled to Rs 6.88 crore from Rs 3.06 crore during the same period.The company plans to use the IPO proceeds for funding incremental working capital, expanding its SIS business model across India, and meeting general corporate purposes.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
as a Reliable and Trusted News Source